Live stream preview
Close Open

Cellares CEO on $380M collaboration with Bristol Myers Squibb and its impact

Floor Talk • 6m 18s

Cellares and Bristol Myers Squibb have entered a $380M collaboration to enhance the manufacturing of CAR T cell therapies.

Cellares Co-Founder & CEO Fabian Gerlinghaus talks about the terms of the agreement, its impact and future partnership plans on #NYSEFloorTalk with Judy Khan Shaw.

Up Next in Floor Talk

×